Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
about
Role of the dental surgeon in the early detection of adults with underlying HIV infection/AIDSInvestigation of false positive results with an oral fluid rapid HIV-1/2 antibody testEvaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India.Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance.eTEST: Developing a Smart Home HIV Testing Kit that Enables Active, Real-Time Follow-Up and Referral After TestingFalse positive rate of rapid oral fluid HIV tests increases as kits near expiration date.Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting.Monitoring temporal changes in the specificity of an oral HIV test: a novel application for use in postmarketing surveillance.Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural ZimbabweFinger-stick whole blood HIV-1/-2 home-use tests are more sensitive than oral fluid-based in-home HIV tests.Accuracy of un-supervised versus provider-supervised self-administered HIV testing in Uganda: A randomized implementation trialA qualitative analysis of the barriers and facilitators of HIV counselling and testing perceived by adolescents in South AfricaAssessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand.Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings.Implementing a novel citywide rapid HIV testing campaign in Washington, D.C.: findings and lessons learnedInitial Accuracy of HIV Rapid Test Kits Stored in Suboptimal Conditions and Validity of Delayed Reading of Oral Fluid Tests.Scope of rapid HIV testing in urban U.S. hospitalsOral rapid test: an alternative to traditional HIV screening in ChileRapid human immunodeficiency virus test quality assurance practices and outcomes among testing sites affiliated with 17 public health departments.Routine rapid HIV screening in six community health centers serving populations at riskImmunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing.Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.2014 European Guideline on HIV testing.Progress toward implementation of integrated systems for surveillance of HIV infection and morbidity in the United States.Multinational assessment of blood-borne virus testing and transfusion safety on the African continent.Provider-related barriers to rapid HIV testing in U.S. urban non-profit community clinics, community-based organizations (CBOs) and hospitals.Mucosal fluids and biomarkers of clinical disease: workshop 3B.Evaluation of the performance characteristics of 6 rapid HIV antibody tests.Human anti-HIV IgM detection by the OraQuick ADVANCE® Rapid HIV 1/2 Antibody Test.2008 European Guideline on HIV testingReaching and Retaining High-Risk HIV/AIDS Clients Through the Internet
P2860
Q26825567-016B8B3A-2544-4BE5-91B5-293F9C9A6054Q28469118-075FD2CC-5B84-4039-8CB7-C13C9BC78659Q33281755-68199E9D-8BE6-49E0-8BBA-3182A75469CAQ33318444-55E7C047-BF57-4D22-A487-21465835FEA5Q33454407-EAC13EC1-ABCC-4DF2-AA65-2424BF46AC2FQ33518551-5D111914-CAD6-4017-8C47-33E877D85B0AQ33640329-C5E600BD-2897-4775-B951-C06630E09FE9Q33682061-0EFAF21D-3515-4AA2-BBBF-9704D1089075Q33796949-51F3D4B3-9278-4936-88FD-881FAB687297Q33817600-F1EC0DDC-A691-4784-AA98-3B26F60C7423Q34283148-84AC53FD-C3E5-4D37-806E-26E4E3FF0DFAQ35677919-D7012979-E77B-436F-A9B0-CF10C573D39EQ35881894-404104C1-AAE6-4FE1-9E58-C300A848D9B0Q35920210-50162449-B961-4359-9815-712DC2D08713Q36004968-834B5D54-5315-465F-89E1-78C362006240Q36059725-14205139-08C2-473C-8629-DD5E0328B2CAQ36726535-C6B56B57-3DB4-4008-AA27-1BCF8BC1E32FQ36876807-5BF0EAAA-5B5A-4937-9685-771A92EF9008Q37374920-A155169E-5FDE-4C69-A844-56B03798F8CCQ37456511-BFE98E35-01A0-4CCB-A719-F09A6D6C43E6Q37613666-6CB33FF6-B536-4F3C-9572-E6C8FF0F06E7Q39895599-8439EFAA-77CB-4943-913F-F70D16F59CE1Q42218121-42ED8DC8-C4F8-4F3B-A787-7B6584FB67CBQ42947394-95A993B5-61F0-4BF1-BE35-E3CC8FC7DE09Q42982287-7CE63153-753D-4D73-A8A2-B27B5079098AQ43979551-0CDE10F4-DFDA-4ABE-9B4C-EA8923F9DAC3Q45154297-6843FD2A-0911-4329-92AD-91285E036511Q46014555-9A69DDA9-4630-4CC8-927A-89D3667F04D5Q54261733-F4D23437-560A-4C22-BCBC-E1793C88FBE3Q56782771-E40D3238-5C86-4956-B336-CDACC381517CQ59237900-11D826FE-5D5A-409C-AC0E-FBF5ABF38BFF
P2860
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
@en
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
@nl
type
label
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
@en
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
@nl
prefLabel
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
@en
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
@nl
P2093
P1433
P1476
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.
@en
P2093
Duncan A MacKellar
Julia H Zhu
Laura G Wesolowski
Post-marketing Surveillance Team
Steven F Ethridge
Teri Dowling
P304
P356
10.1097/01.AIDS.0000238413.13442.ED
P407
P577
2006-08-01T00:00:00Z